G
Gangadhar Taduri
Researcher at Nizam's Institute of Medical Sciences
Publications - 23
Citations - 389
Gangadhar Taduri is an academic researcher from Nizam's Institute of Medical Sciences. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 6, co-authored 23 publications receiving 281 citations.
Papers
More filters
Journal ArticleDOI
Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy
Jason Glaser,Jay Lemery,Balaji Rajagopalan,Henry F. Diaz,Ramón García-Trabanino,Gangadhar Taduri,Magdalena Madero,M. D. Amarasinghe,Georgi Abraham,Sirirat Anutrakulchai,Vivekanand Jha,Peter Stenvinkel,Carlos A. Roncal-Jimenez,Miguel A. Lanaspa,Ricardo Correa-Rotter,David Sheikh-Hamad,Emmanuel A. Burdmann,Ana Andres-Hernando,Tamara Milagres,Ilana Weiss,Mehmet Kanbay,Catharina Wesseling,Laura G. Sánchez-Lozada,Richard J. Johnson +23 more
TL;DR: Climate change has led to significant rise of 0.8°C-0.9°C in global mean temperature over the last century and has been linked with significant increases in the frequency and severity of heat waves (extreme heat events).
Journal ArticleDOI
Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
Maaz Shaikh,Mark Woodward,Oommen John,Abhinav Bassi,Stephen Jan,Manisha Sahay,Gangadhar Taduri,Martin Gallagher,John Knight,Vivekanand Jha +9 more
Journal ArticleDOI
Chronic kidney disease of unknown etiology: Case definition for India – A perspective
TL;DR: This article presents the diagnostic criteria for CKDu proposed in a consensus meeting at Chennai, India, in May 2017 and is presented as a comprehensive definition to identify the cases accurately to ease clinical diagnosis and facilitate screening of populations in affected areas.
Journal ArticleDOI
A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia.
Pingali Usharani,Chandrasekhar Nutalapati,Venkata K. Pokuri,Chiranjeevi Uday Kumar,Gangadhar Taduri +4 more
TL;DR: T. bellerica has the potential for treating hyperuricemia as it was devoid of any serious adverse effects in the present study and further studies are needed to confirm this potential.
Journal ArticleDOI
Revisiting renal amyloidosis with clinicopathological characteristics, grading, and scoring: A single-institutional experience.
Abhiram Kalle,Archana Gudipati,Sree Bhushan Raju,Karthik Kalidindi,Swarnalatha Guditi,Gangadhar Taduri,Megha S Uppin +6 more
TL;DR: Clinical history, IF, and IHC are essential in amyloid typing because they provide a subtle guide regarding the severity of disease in the background of a wide range of morphological features and biochemical values.